Browse Articles

Discover research articles across all indexed journals

Overall Survival Among Patients With Hepatocellular Carcinoma Treated With External Beam Radiation Therapy: Individual Patient Data Outcomes From a Multinational Cohort

Journal of Clinical Oncology Andrew M. Moon, Ted K. Yanagihara, Laura A. Dawson et al. Jul 01, 2026 DOI: 10.1200/jco-25-02399

PURPOSE External beam radiation therapy (EBRT) has gained delayed acceptance as a recommended first-line treatment modality for patients with hepatocellular carcinoma (HCC), given limited evidence that it improves overall survival (OS). We analyzed individual patient data (IPD) from an international cohort to assess OS among patients with HCC treated with EBRT. METHODS We performed a systematic review of publications that assessed EBRT, met prespecified technical standards for HCC, and reported OS (search date December 15, 2022). Corresponding authors were invited to submit IPD for the study. We performed Kaplan-Meier survival analyses to determine OS and restricted mean survival time (RMST) stratified by Barcelona Clinic Liver Cancer (BCLC) stage and treatment status (ie, treatment-naïve and experienced). We performed random effects Cox proportional hazards modeling to assess clinical characteristics associated with OS. RESULTS Data were provided on 4,913 patients treated with EBRT with a median follow-up time of 5.0 years. The median OS was 6.8 years (95% CI, 5.7 to 8.7) for BCLC-0 and 4.6 years (95% CI, 4.1 to 5.1) for BCLC-A. Among treatment-naïve patients, the median OS was not reached (95% CI, 8.6 to not reached) for BCLC-0 and was 5.4 years (95% CI, 4.5 to 6.7) for BCLC-A. In multivariable models, more advanced BCLC stage, higher tumor burden, worse performance status, and Child-Pugh class B or C were associated with a higher risk of mortality. Ablative radiation dose and more recent year of treatment were associated with a reduced risk of death. CONCLUSION To our knowledge, this study represents the largest multinational cohort of patients with HCC treated with EBRT. OS outcomes with EBRT for very early- and early-stage HCC appear to be comparable with resection, thermal ablation, and other ablative locoregional therapies. These data support the inclusion of EBRT in the BCLC HCC clinical decision-making process.

Accessing Medium-Sized Bridged Heterocycles via EnT-Catalyzed Intermolecular Dearomative (5 + 4) Cycloaddition of Furans and Oxazoles

Journal of the American Chemical Society Carla Hümpel, Debanjan Rana, Sophie Korgitzsch et al. Jul 01, 2026 DOI: 10.1021/jacs.6c00671

Catalytic Selective Deoxygenation and Deamination of Amides to Access Alkenes

Angewandte Chemie International Edition Qiu Shi, Wenbo H. Liu Jul 01, 2026 DOI: 10.1002/anie.4999077

ABSTRACT Amide derivatizations are important and useful transformations in organic chemistry, owing to the ready accessibility of amides. However, reported methodologies to date have been limited to either deoxygenative or deaminative pathways; the direct, single‐step conversion of amides into hydrocarbons has remained elusive. In this work, by employing 9‐borabicyclo[3.3.1]nonane (9‐BBN) as the reductant and Cp 2 ZrCl 2 as a precatalyst, we demonstrate that amides can be efficiently converted to alkenes under simple and mild conditions, which represents the third mode of amide derivatization after deoxygenation and deamination. Mechanistic investigations reveal that 9‐BBN is crucial for the tandem C─O and C─N cleavage. This transformation links the two fundamental functional groups such that the richness of amide retrosynthesis is applied to alkenes.

KMT2D depletion promotes KRAS-induced pancreatic carcinogenesis independent of TP53

Journal of Biological Chemistry Ezequiel J. Tolosa, Glancis L. Raja Arul, Ashley N. Sigafoos et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113203

Perioperative predictors of outcomes in head and neck cancer surgery: A prospective observational analysis.

Journal of Clinical Oncology Pushplata Gupta, Monika Tak, Akshay Jain et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.234

234 Background: Surgical outcomes in head and neck cancer (HNC) are influenced by patient-related factors (nutritional status, comorbidities), disease-related factors (tumor stage and type), and perioperative variables (surgical duration, anesthetic management). Despite the high global incidence of HNC, comprehensive prospective data evaluating perioperative predictors of outcomes remain limited, highlighting the need for systematic investigation in this area. Methods: This prospective, single-center observational study was conducted following Institutional Ethics Committee approval and prospective CTRI registration (CTRI/2025/10/096289; registered on 22/10/2025). Patient enrollment began on 05/11/2025. Adults undergoing major HNC surgery were included. Data collected encompassed demographics, comorbidities, medications, nutritional status, and detailed intraoperative anesthetic variables, including fluid therapy, vasopressor use, duration of hypotension, and blood loss. The primary outcome was a composite of 30-day major complications (Clavien–Dindo grade ≥III) and mortality. The planned sample size is 1,540 participants, with a recruitment period of two years and an additional one-year follow-up. Interim analyses were performed on the initial cohort. Results: In the first 100 enrolled patients (mean age 52 years; 74% male), comorbidity burden was substantial (ASA ≥III: 20%; median Caprini score: 5). Major complications or death within 30 days occurred in 15% of patients. Increased intraoperative blood loss emerged as the strongest independent predictor of adverse outcomes, while higher Caprini scores showed a trend toward increased risk. These findings highlight blood loss as a key modifiable perioperative factor and support the utility of the Caprini score for preoperative risk stratification in HNC surgery. Conclusion: Preliminary results from this ongoing study demonstrate a high prevalence of nutritional deficits and intraoperative hemodynamic instability in patients undergoing major HNC surgery. These perioperative factors represent potential targets for intervention to improve early postoperative outcomes. Continued recruitment and long-term follow-up are underway to further clarify predictors of short- and long-term survival. Conflict of Interest: None declared. Funding: Investigator-initiated study with no external funding. Characteristic All patients (N=100) No major comp. (n=85) Major comp. (n=15) p-value Age (years), mean ± SD 52.4 ± 11.9 51.6 ± 11.7 56.9 ± 12.1 0.098 BMI (kg/m²), mean ± SD 24.1 ± 4.5 24.3 ± 4.6 23.2 ± 3.5 0.386 ASA grade ≥3 20 (20.0) 14 (16.5) 6 (40.0) 0.045 Caprini score, median (IQR) 5 (5–6) 5 (5–6) 6 (5–7) 0.029 Surgery duration (min), mean ± SD 342 ± 82 334 ± 78 386 ± 96 0.023 Blood loss (mL) median (IQR) 700 (500–900) 650 (400–850) 900 (700–1200) 0.005

Interaction of Molecular Hydrogen on α-Pu at 300 K: Nucleation of Hydrides and Pu-Catalyzed Carbides

Journal of the American Chemical Society Daniel J. Rodriguez, Timothy J. Gorey, Raymond Atta-Fynn et al. Jul 01, 2026 DOI: 10.1021/jacs.6c03998

Ultranarrow‐Spaced Polar Green Aromatic Dion–Jacobson Hybrid Perovskite Enables Highly Sensitive and Stable Self‐Powered X‐Ray Detection

Advanced Materials Huawei Yang, Lan Zhou, Jianbo Wu et al. Jul 01, 2026 DOI: 10.1002/adma.73657

ABSTRACT Dion‐Jacobson (DJ) hybrid perovskites are considered as highly promising X‐ray detection materials due to their high stability and short interlayer spacing. However, the large‐scale commercial development of these materials is challenged due to severe ion migration at high voltage and lead toxicity. Here, we successfully obtained a DJ‐type polar lead‐free green hybrid perovskite (4AMPY) 2 AgBiBr 8 ( 1 ) by inserting 4‐aminomethylpyridine (4AMPY) aromatic diamine into 3D Cs 2 AgBiBr 6 , and achieved efficient and stable self‐powered X‐ray detection. Specifically, owing to the insertion of 4AMPY, 1 crystallizes in polar space group P 2 1 and exhibits a significant bulk photovoltaic effect. Additionally, strong hydrogen‐bonding interactions between 4AMPY and adjacent inorganic layers lead to an ultranarrow interlayer spacing of 3.09 Å. Meanwhile, the enhanced electron cloud density in aromatic diamines improves the charge transfer channel of 1 and enhances its X‐ray detection performance. Therefore, among all DJ‐type lead‐free hybrid perovskites, 1 achieves record‐breaking sensitivities of 661.4 and 9465.2 µC Gy −1 cm −2 at 0 and 100 V, respectively. Importantly, 1 exhibits excellent storage stability, with its sensitivity remaining at 97.5% (0 V) and 96.6% (100 V) of the initial value after three months. This work will greatly promote the development of polar DJ‐type lead‐free perovskite‐based self‐powered X‐ray detectors.

A Super‐Adhesive Air Filter With Capillarity‐Mediated Spontaneous Particle Absorption via Dynamic Bond Exchange

Advanced Materials Junyong Park, Hyeri Jeon, Hyunwoong Park et al. Jul 01, 2026 DOI: 10.1002/adma.202600006

ABSTRACT A strategy to coat a thin liquid film over substrates enables strong particle adhesion via capillary force. However, the practical utility of a liquid film is hindered by inherent fluid instabilities, including the Plateau‐Rayleigh instability, interfacial dewetting, and drainage. Here, we introduce dynamically crosslinked adhesive films that maintain an elastic network to ensure structural integrity while enabling viscous, capillarity‐driven particle adhesion. Polydimethylsiloxane with an imine crosslinked network is applied as a viscoelastic adhesive. While the elastic nature allows for stable and thick films, it remains sufficiently viscous to form a meniscus upon particle contact; this generates a micro‐Newton scale, strong capillary force. When applied to air filters, which typically rely on nano‐Newton scale van der Waals adhesion, the dynamically crosslinked adhesive improves filtration performance and suppresses particle resuspension. Rather than only retaining particles on the surface, the adhesive layer with dynamic imine bonds actively absorbs particles into the matrix, which then exposes a fresh sticky surface for sustained filtering and prolongs the increase in pressure drop by filtering. Therefore, operational lifetime of the filter is extended compared to conventional filters, even with more effective filtration. These unique particle capturing characteristics of a stable dynamic bond adhesive layer not only exhibits outstanding filtration performances, but also proposes a new paradigm of air purification technologies.

Correction: A Single Chondroitin 6-Sulfate Oligosaccharide Unit at Ser-2730 of Human Thyroglobulin Enhances Hormone Formation and Limits Proteolytic Accessibility at the Carboxyl Terminus

Journal of Biological Chemistry Marisa Conte, Alessia Arcaro, Daniela D'Angelo et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113172

Prognostic value of pretreatment systemic immune-inflammation index towards tumor response in patients with locally advanced cervical cancer treated with definitive radiotherapy in Indonesia.

Journal of Clinical Oncology Yoga Dwi Oktavianda, Irwan Ramli, Arie Munandar et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.216

216 Background: The systemic immune-inflammation (SII) is a parameter reflecting immune and inflammatory response. However, the optimal SII cut-off values vary across populations and disease entities. This study aims to evaluate the prognostic value of SII towards tumor response among patients with locally advanced cervical cancer (LACC) in Indonesia. Methods: We conducted a retrospective study of patients with LACC who underwent definitive (chemo)radiotherapy at Dr. Cipto Mangunkusumo Hospital, Indonesia, in 2019 - 2021. Clinical, tumor-related, laboratory, and treatment-related data were collected from medical records. Tumor response was assessed using radiologic imaging following completion of radiotherapy, divided into complete and non-complete response. The SII was calculated based on platelet count and neutrophil-lymphocyte ratio. The optimal SII cut-off value was determined using ROC curve analysis. Factors associated with tumor response were evaluated using bivariate and multivariate analyses. Results: This study included 130 eligible patients, with a mean age of 51 years. Most patients were diagnosed with stage III (83.1%), squamous cell carcinoma (82.3%), and nodal involvement (73.8%). Complete response was achieved in 66.9% of patients following radiotherapy, with a median total dose of 80 Gy. The optimal SII cut-off value for this population was 1900 x 10 3 cell/µL (AUC: 0.643; p = 0.008). Based on bivariate and multivariate analysis, a low baseline SII (hazard ratio [HR]: 2.87; p = 0.031) and administering concurrent chemoradiotherapy (CCRT) (HR: 3.22; p = 0.007) were the only factors independently associated with better tumor response. Conclusions: Pre-treatment SII is a reliable predictor of tumor response in LACC patients, with improved responses observed in patients receiving concurrent chemoradiotherapy. Bivariate and multivariate analysis for tumor response. Variables Median/ Ref. HR (95% CI) in bivariate analysis P value HR (95% CI) in multivariate analysis P value Stage II, III, IV 2.26 (0.80 – 6.43) 0.126 1.12 (0.36 – 3.49) 0.847 Tumor size (cm) < 4 vs > 4 1.85 (0.72 – 4.73) 0.200 1.28 (0.45 – 3.65) 0.642 Histopathology SCC vs others 1.38 (0.54 – 3.50) 0.498 Nodal involvement + vs - 0.87 (0.38 – 1.99) 0.749 Hemoglobin (g/dL) < 10 vs > 10 0.55 (0.26 – 1.16) 0.113 1.03 (0.42 – 2.49) 0.954 Leukocyte (10 3 cell/µL) < 10 vs > 10 1.60 (0.75 – 3.41) 0.224 1.01 (0.41 – 2.53) 0.982 SII (10 3 cell/µL) < 1900 vs > 1900 3.21 (1.50 – 6.86) 0.003* 2.87 (1.10 – 7.51) 0.031* Treatment CCRT vs RT 3.87 (1.79 – 8.35) 0.001* 3.22 (1.38 – 7.49) 0.007* OTT (days) < 85 vs > 85 1.71 (0.82 – 3.58) 0.155 2.17 (0.93 – 5.05) 0.073 CCRT: concurrent chemoradiotherapy; OTT: overall treatment time; RT: radiotherapy; SCC: squamous cell carcinoma; SII: systemic immune inflammation. *Logistic regression test (p<0.05).

Metal‐Free Photocatalytic CO <sub>2</sub> Reduction to Formate Driven by Visible Light via a Consecutive Photoinduced Electron Transfer Mechanism

Angewandte Chemie International Edition Xianjun Yin, Jingjie Hu, Heng Wu et al. Jul 01, 2026 DOI: 10.1002/anie.1083625

ABSTRACT Realizing efficient and selective photocatalytic CO 2 reduction (PCO 2 R) using metal‐free organic systems under visible light remains a significant challenge. Here, we report the first metal‐free, self‐sensitized molecular photocatalyst capable of driving visible‐light‐induced CO 2 ‐to‐HCOO − conversion via a consecutive photoinduced electron transfer (ConPET) mechanism. The rationally designed BPI‐OMe, featuring an electron‐donating group, demonstrates exceptional performance under visible light irradiation, achieving a formate production rate of 27.51 mmol g −1  h −1 with &gt; 99% selectivity. This outstanding activity stems from its optimized electronic properties: a low excitation energy (2.98 eV), a long‐lived charge‐separated anion radical state ( τ = 806.94 ns), a high‐energy SOMO level (−3.47 eV), and strong CO 2 binding affinity (−0.147 eV). In situ ESR and ultrafast spectroscopic analyses reveal the ConPET process: sequential photon absorption enables electron transfer from ascorbic acid to BPI‐OMe, generating BPI‐OMe, followed by electron delivery to CO 2 to form CO 2 − , which is subsequently converted to formate through a hydrogen atom transfer. This work not only represents a breakthrough in metal‐free PCO2R but also provides a general molecular design strategy based on multi‐photon charge accumulation for enabling challenging solar‐to‐chemical transformations.

Lamellar‐Paracrystallinity‐Controlled Thermal Transport in Polymer Semiconductors

Advanced Materials Nai‐Fu Liu, Xiao‐Yan Zhang, Yi‐Fan Huang et al. Jul 01, 2026 DOI: 10.1002/adma.73680

ABSTRACT Understanding thermal transport in polymer semiconductors is crucial for thermal management in organic electronic and energy‐harvesting devices, directly affecting their performance, safety and long‐term stability. However, the structure‐property relationship and underlying thermal transport physics remain largely unexplored. Herein, thermal conductivities of 11 representative polymer semiconductors were measured using an improved suspended‑3 ω technique, revealing a strong correlation between thermal conductivity and the paracrystalline disorder of lamellar packing. It is observed that the in‑plane intrinsic thermal conductivity of polymer semiconductor films is predominantly controlled by lamellar paracrystallinity, rather than backbone chemistry or π–π stacking. Tuning lamellar paracrystallinity within the same polymer modulated thermal conductivity by up to ∼40%. Our work shows that lamellar packing is the primary interchain thermal transport pathway, with more efficient vibrational coupling than π–π stacking as evidenced by molecular dynamics simulations. This physical picture reveals distinct interchain pathways for charge and thermal transport in polymer semiconductors, providing guidelines for manipulating thermal conductivity without affecting electrical performance in advanced organic materials and devices.

Prion propagation is controlled by discrete structural regions of PrP rather than overall stability

Journal of Biological Chemistry Savroop K. Bhamra, Parineeta Arora, May Liew et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113157

Prognostic significance of undetectable baseline HPV circulating tumor DNA in oropharyngeal cancer.

Journal of Clinical Oncology Justin Albert Fortino, Aatish Sunder, Rex Lee et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.240

240 Background: Patients with p16-associated oropharyngeal squamous cell carcinomas (OPSCC) generally experience favorable treatment outcomes; however, 10-25% develop progression despite favorable clinical staging. Some reports have posited that undetectability of tumor tissue-modified viral (TTMV)-HPV circulating tumor DNA (ctDNA) may be an unfavorable prognostic feature. We examined for the presence of relationships between baseline HPV ctDNA positivity, anatomic staging, tumor volume, and early progression risk. Methods: We retrospectively analyzed 89 patients with OPSCC who underwent baseline HPV ctDNA testing between August 2021 and December 2025 at a single institution. ctDNA levels were quantified in fragments/mL and analyzed as log10 transformed values using a commercially available HPV ctDNA assay (NavDx; Naveris, Waltham, MA). Clinical stage (AJCC 8 th edition), CT or MRI-derived gross tumor volume (GTV), and survival outcomes were collected. Progression-free survival (PFS) was assessed using the Kaplan-Meier method. Pearson correlation was used to determine statistical association. Multivariable logistic regression models with TNM Stage and ctDNA covariates evaluated the incremental prognostic contribution of HPV ctDNA beyond anatomic disease burden. Results: Of the 89 patients, 75 (84%) had HPV16, 2 (2%) had HPV18, 2 (2%) had HPV33, 2 (2%) had HPV35, and 8 (9%) had no identified high-risk HPV subtype. Median follow-up was 15.9 months (IQR 11.1-21.0). Baseline ctDNA was detectable in 79 patients (89%) and across all AJCC group stages (Stage I: 87%, Stage II: 95%, Stage III: 93%, Stage IV: 100%). Baseline ctDNA levels increased numerically with advancing stage but substantial intra-stage heterogeneity was observed. A weak positive association with GTV (r = 0.19) was observed with rising ctDNA levels. Five patients (5.6%) experienced disease progression at a median of 3.5 months from baseline ctDNA test (IQR 2.2-8.2); all had detectable baseline ctDNA. Two-year PFS did not significantly differ by ctDNA positivity (93% vs. 100%, p = 0.43). Addition of ctDNA positivity to AJCC TNM staging did not significantly improve discrimination for progression (AUC 0.91 vs. 0.92). Conclusions: In this single institution cohort, undetectability of baseline TTMV-HPV ctDNA did not demonstrate prognostic value beyond AJCC staging. A weak correlation with tumor volume and intra-stage heterogeneity suggests that ctDNA may reflect biological features beyond anatomic disease burden. Further investigation is needed to determine if alternative testing methods would produce a closer association with prognosis.

Interrogating Cholinergic Chemical Transmission of U-87 MG Glioblastoma Cells with Nanoelectrochemistry

Journal of the American Chemical Society Siao-Han Huang, Mahmuda Akter, Conrad B. Milton et al. Jul 01, 2026 DOI: 10.1021/jacs.6c04969

High Throughput X‐Ray Characterization of Defects in Wide‐Bandgap Semiconductors

Advanced Materials Tia Gray, Elias J. Garratt, Xiang Zhang et al. Jul 01, 2026 DOI: 10.1002/adma.73678

ABSTRACT Wide‐bandgap materials are central to next‐generation high‐power, radio‐frequency, and quantum technologies, yet their performance is often limited by crystalline defects such as dislocations. Single‐crystal diamond in particular exhibits exceptional electronic and thermal properties, however, accurately and scalably quantifying defect density remains challenging. Here, we present an integrated methodology for characterizing dislocation densities in diamond using high‐resolution X‐ray diffraction and validate it using complementary Raman spectroscopy, hydrogen etch‐pit analysis, and Hall effect measurements. Central to this approach is a custom Python‐based tool that processes X‐ray rocking curves and reciprocal space maps. The framework is applied to four commercially available grades of diamond substrates, spanning a wide defect density range (∼10 5 to 10 8 cm −2 ). Consistent trends are observed across all characterization techniques, with electronic‐grade diamond exhibiting the highest crystalline quality and lowest defect density. Application of the analysis tool to GaN samples further demonstrates its adaptability to other wide‐bandgap material systems. Overall, this work establishes a robust, scalable, and versatile platform for high‐throughput defect analysis in diamond and related wide‐bandgap semiconductors.

HSP90 Inhibition Partially Rescues Alternative Splicing Dysregulation in Cell Models of Myotonic Dystrophy

Journal of Biological Chemistry Jing Zhang, Amy Mascorro, Humayra Oishi et al. Jul 01, 2026 DOI: 10.1016/j.jbc.2026.113354

Understanding the impact of the Cancer Drug List on clinicians' prescription patterns in Singapore: A qualitative study.

Journal of Clinical Oncology Mahendran Karnagaran, Chin-Wen Chong, Christina Misa Wong et al. Jul 01, 2026 DOI: 10.1200/jco.2026.44.19_suppl.316

316 Background: The Cancer Drug List (CDL) introduced by Singapore’s Ministry of Health in September 2022 aligns insurance reimbursement with a list of clinically proven and cost-effective oncology drugs. National spending on cancer drugs doubled between 2015 and 2019. Although most patients did not experience an increase in out-of-pocket expenses (OOPE) immediately after CDL implementation, financial distress and high financial toxicity (FT) remain prevalent among patients undergoing chemotherapy. The impact of the CDL on clinicians’ prescribing behaviour has not been well described. This study examined how CDL implementation reshaped prescribing priorities. Methods: We conducted a qualitative descriptive study using semi-structured interviews with clinicians who prescribed systemic cancer therapies. Participants were recruited at a public cancer centre in Singapore and were interviewed in English between November to December 2025. Interviews were audio-recorded, transcribed, and analysed using applied thematic analysis. Results: 12 clinicians were interviewed (median age 40 years; median 15.5 years in medical practice; 75% female). Three dominant shifts in prescribing behaviour emerged following CDL implementation: recalibration toward subsidy eligibility, heightened cost consciousness, and differential access across tumour types. Prior to CDL implementation, prescribing decisions were guided by financial considerations, adherence to clinical guidelines, strength of evidence, and toxicity profiles. Clinicians described working within insurance claim limits. Post-CDL, prescribing became closely anchored to CDL inclusion, as subsidy eligibility directly determined OOPE. Clinicians reported systematically verifying whether regimens were CDL-listed before finalising treatment plans. While first-line therapies were generally perceived as accessible, subsequent lines of therapy and non-listed indications posed greater financial challenges. Access was described as straightforward for common cancers (e.g., breast), but clinicians highlighted disproportionate financial barriers for rare cancers and tumour types not aligned with CDL indications. Increased cost awareness led to more cost-related discussions and treatment sequencing adjustments. However, limited visibility into patients’ exact out-of-pocket costs hindered precise financial counselling. Conclusions: CDL implementation anchored prescribing towards subsidy eligibility and cost alignment. In the context of persistent patient-reported FT and ongoing concerns about affordability despite stable OOPE for many patients, strengthening financial transparency tools and referral pathways may enhance clinicians’ capacity to support informed, cost-sensitive treatment decisions. Further research is underway to examine patient experiences post- CDL implementation.

X-ray-Triggered Prodrug Activation in a Nanoscale Metal–Organic Framework for Spatially Confined Chemoradiotherapy

Journal of the American Chemical Society Yuxuan Xiong, Yibin Mao, Chenghua Deng et al. Jul 01, 2026 DOI: 10.1021/jacs.6c03407

Quantifying Deep‐Level Defects‐Dominated Degradation for Commercially Viable Perovskite Solar Cells

Advanced Materials Qiu Xiong, Can Wang, Xiaofeng Huang et al. Jul 01, 2026 DOI: 10.1002/adma.73679

ABSTRACT The unclear mechanisms and dominant types of defects causing degradation hinder the stability of perovskite solar cells, leading to increased operating costs and limiting their commercialization. In this study, we identify deep‐level I FA and I Pb defects as the primary cause of device degradation based on quantitative analysis of capacitance‐frequency spectra combined with detailed balance theory, although the concentrations are lower than those of commonly believed shallow‐level defects by three orders of magnitude. To mitigate these issues, we design a non‐intercalary ligand coordination strategy through dual‐end electropositive 3TU 2+ ions, which effectively passivated the degradation‐induced deep‐level defects. This approach results in a significant improvement in quasi‐Fermi level splitting alignment, reducing energy loss at the rear interface by an order of magnitude (from 1.46% to 0.62%). In addition to achieving a certified efficiency of 25.56%, our devices demonstrate an extrapolated T 80 lifetime exceeding 10 years, as per the ISOS‐LC‐1 protocol. This improvement reduces the levelized cost of energy to 0.148$ kWh −1 , on par with silicon photovoltaics, thus enhancing the commercial viability of perovskite solar cells.